Ma EZ, Bao A, Ahmadi M, Zhang J, et al. Dupilumab is associated with reduced risk of acute upper respiratory infections in atopic dermatitis patients compared to non-targeted immunosuppressants: a multi-center cohort study. J Am Acad Dermatol 2024 Aug 30:S0190-9622(24)02756.
PMID: 39218355